Stories 3 results of 62

Amgen Licenses Lung Cancer Technology

Tesaro Inc., a Boston cancer drug start-up, has signed an exclusive licensing deal with Amgen Inc. to develop some of the Thousand Oaks biotech giant’s technology into a potential lung cancer drug.

U.K. Agency Opposes Ticketmaster-Live Nation Merger

The U.K. Competition Commission on Thursday provisionally ruled against the proposed merger of two Los Angeles-based live entertainment companies.

Amgen Drug Wins Fast-Track Status

The U.S. Food and Drug Administration has granted fast-track designation for ivabradine, a heart drug licensed for sale by Amgen Inc. in Thousand Oaks.

More Stories

Create search alert for "이천출장안마▨ㄲr톡 GTTG5▨㳒이천태국안마이천방문안마䴋이천감성안마䌿이천풀코스안마👩🏽‍🦲inhibitive"